Cargando…

The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models

Detalles Bibliográficos
Autores principales:	Shirakawa, K, Naitou, K, Hirose, J, Nakamura, M, Takeuchi, T, Hosaka, Y, Furusako, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254937/ http://dx.doi.org/10.1186/cc9122

Ejemplares similares

Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model
por: Nakamura, M, et al.
Publicado: (2008)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models
por: Nakamura, Masaki, et al.
Publicado: (2007)

Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis in systemic inflammatory response syndrome
por: Shozushima, T, et al.
Publicado: (2011)

Presepsin (sCD14-ST) as a new diagnostic biomarker of sepsis: development of diagnostic tools using the whole blood
por: Shozushima, T
Publicado: (2011)

Compared values of presepsin (sCD14-ST) and procalcitonin as early markers of outcome in severe sepsis and septic shock: a preliminary report from the Albumin Italian Outcome Sepsis (ALBIOS) study
por: Caironi, P, et al.
Publicado: (2013)

The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis
por: Zhang, Xin, et al.
Publicado: (2015)

Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis
por: van Maldeghem, Iris, et al.
Publicado: (2019)

Development of a newly immunoassay specific for mouse presepsin (sCD14-ST)
por: Takahashi, Gaku, et al.
Publicado: (2022)

Usage of procalcitonin and sCD14-ST as diagnostic markers for postoperative spinal infection
por: Zhu, Xi, et al.
Publicado: (2022)

Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?
por: Caglar, Fatma Nihan Turhan, et al.
Publicado: (2017)

Prognostic value of sCD14-ST (presepsin) in cardiac surgery
por: Popov, Dmitry, et al.
Publicado: (2015)

The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis
por: Zhu, Ying, et al.
Publicado: (2019)

Evaluation of a soluble CD14 subtype in patients with surgical sepsis
por: Fukui, Y
Publicado: (2012)

The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels
por: Liu, Zuo-Liang, et al.
Publicado: (2018)

Obesity and inflammatory markers in severe sepsis
por: Simon, P, et al.
Publicado: (2013)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

Induction of severe Staphylococcus aureus sepsis in pigs
por: Iburg, TM, et al.
Publicado: (2009)

Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients
por: Focà, A, et al.
Publicado: (2012)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Relevance of eosinopenia as an early sepsis marker
por: Moura, EB, et al.
Publicado: (2011)

Systemic symptoms as markers for severity in sepsis
por: Edman-Wallér, J, et al.
Publicado: (2015)

New sepsis-related marker: endotoxin activity assay
por: Ikeda, T, et al.
Publicado: (2010)

Neutrophil CD64 as a diagnostic marker of sepsis in neonates: impact on clinical care
por: Kingma, P, et al.
Publicado: (2012)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

Serial change of C1 inhibitor in patients with sepsis: a preliminary report
por: Hirose, T, et al.
Publicado: (2015)

Are phenylcarboxylic acids really markers in severe sepsis?
por: Beloborodova, NV, et al.
Publicado: (2009)

Brain markers of neurodegeneration in sepsis survivor rats
por: de Souza Constantino, Larissa, et al.
Publicado: (2013)

Serum cholesterol level: is it a marker of sepsis?
por: Abraham, B, et al.
Publicado: (2005)

The clinical significance of sCD14-ST for blood biomarker in neonatal hematosepsis: A diagnostic accuracy study
por: Xiao, Ting, et al.
Publicado: (2017)

Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study
por: Foca, A, et al.
Publicado: (2014)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Background factors in patients receiving immunoglobulin administration and changes in sepsis markers
por: Ikeda, T, et al.
Publicado: (2010)

Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study
por: Su, Longxiang, et al.
Publicado: (2012)

Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock
por: Hosaka, Y, et al.
Publicado: (2004)

Monocytic and neutrophilic CD11b and CD64 in severe sepsis
por: Jämsä, J, et al.
Publicado: (2012)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Serial estimation of cytokine markers and their correlation with mortality in elderly patients with sepsis
por: Bhanot, R, et al.
Publicado: (2010)

Endocan can be a predictive marker of severity of sepsis but cannot be a marker of acute respiratory distress syndrome in ICU patients
por: Mizunuma, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ve9qsrts21l2re17082o5r08t